Renal cell carcinoma: Translational aspects of metabolism and therapeutic consequences

Renal cell carcinoma: Translational aspects of metabolism and therapeutic consequences

Show other versions (1)

The heterogeneity of renal cell carcinoma (RCC) poses a challenge for designing clinically applicable diagnostic and screening investigations, predictive and prognostic biomarkers, and targeted molecular therapies. Hereditary RCC syndromes harbor specific driver gene mutations, and their discoveries...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Yang, O, Maxwell, P, Pollard, P
Formatua:	Journal article
Hizkuntza:	English
Argitaratua:	2013

Antzeko izenburuak

Renal cell carcinoma: translational aspects of metabolism and therapeutic consequences.
nork: Yang, O, et al.
Argitaratua: (2013)

Crosstalk Between Metabolism and Immune Activity Reveals Four Subtypes With Therapeutic Implications in Clear Cell Renal Cell Carcinoma
nork: Yi Wang, et al.
Argitaratua: (2022-04-01)

HIF prolyl hydroxylase PHD3 regulates translational machinery and glucose metabolism in clear cell renal cell carcinoma
nork: Petra Miikkulainen, et al.
Argitaratua: (2017-07-01)

Metabolic reprogramming of clear cell renal cell carcinoma
nork: Haiyan Zhu, et al.
Argitaratua: (2023-06-01)

Renal Lipid Metabolism Abnormalities in Obesity and Clear Cell Renal Cell Carcinoma
nork: Ion Alexandru Bobulescu, et al.
Argitaratua: (2021-09-01)

11β-Hydroxysteroid dehydrogenase 1: translational and therapeutic aspects.
nork: Gathercole, L, et al.
Argitaratua: (2013)

Targeting ferroptosis in renal cell carcinoma: Potential mechanisms and novel therapeutics
nork: Lei Yang, et al.
Argitaratua: (2023-08-01)

Therapeutic targeting of P2X4 receptor and mitochondrial metabolism in clear cell renal carcinoma models
nork: Christofer Rupert, et al.
Argitaratua: (2023-05-01)

Cuproptosis: A potential therapeutic target in clear cell renal cell carcinoma
nork: Yuetong Zhao, et al.
Argitaratua: (2024-06-01)

Cholesterol metabolism related-intermediates and genes in clear cell renal cell carcinoma
nork: D. Loizzo, et al.
Argitaratua: (2020-10-01)

Abnormal cholesterol metabolism in renal clear cell carcinoma
nork: R L Gebhard, et al.
Argitaratua: (1987-10-01)

Relevance and therapeutic possibility of PTEN-long in renal cell carcinoma.
nork: Hui Wang, et al.
Argitaratua: (2015-01-01)

SHMT as a Potential Therapeutic Target for Renal Cell Carcinoma
nork: Yongli Situ, et al.
Argitaratua: (2023-09-01)

Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinoma
nork: Alessandra Scagliola, et al.
Argitaratua: (2021-08-01)

Doxycycline sensitizes renal cell carcinoma to chemotherapy by preferentially inhibiting mitochondrial translation
nork: Bo Wang, et al.
Argitaratua: (2021-10-01)

ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma
nork: Philipp Seidel, et al.
Argitaratua: (2022-12-01)

Identification of metabolic dysregulation and biomarkers for clear cell renal cell carcinoma
nork: Bin Zheng, et al.
Argitaratua: (2024-12-01)

Diagnostic and therapeutic aspects of recurrent renal stone disease
nork: Anthony Meyers, et al.
Argitaratua: (1998-01-01)

Correction: Metabolic Factors Associated with Risk of Renal Cell Carcinoma
Argitaratua: (2013-01-01)

Correction: Metabolic Factors Associated with Risk of Renal Cell Carcinoma.
nork: Christel Häggström, et al.
Argitaratua: (2013-01-01)

542 TIGIT as a potential therapeutic target in renal cell carcinoma
nork: Mario Sznol, et al.
Argitaratua: (2023-11-01)

Research Progress on Ferroptosis as a Therapeutic Strategy in Renal Cell Carcinoma
nork: Minna Liu, et al.
Argitaratua: (2022-12-01)

Use of Circular RNAs in Diagnosis, Prognosis and Therapeutics of Renal Cell Carcinoma
nork: Rebeca Osca-Verdegal, et al.
Argitaratua: (2022-06-01)

The role and therapeutic significance of the anoikis pathway in renal clear cell carcinoma
nork: Jin Wang, et al.
Argitaratua: (2022-09-01)

CircRNAs as Novel Biomarkers and Therapeutic Targets in Renal Cell Carcinoma
nork: Yuxia Zhou, et al.
Argitaratua: (2022-02-01)

In vitro evidence for a new therapeutic approach in renal cell carcinoma
nork: Carmine Pittoggi, et al.
Argitaratua: (2008-08-01)

Editorial: Interplay Between Autophagy and Metabolic Syndrome: Causes, Consequences and Therapeutic Challenges
nork: Stephen F. Rodrigues, et al.
Argitaratua: (2021-10-01)

[Translated article] Spiny Keratoderma as a Paraneoplastic Condition in Clear Cell Renal Cell Carcinoma
nork: L. Linares-Gonzalez, et al.
Argitaratua: (2022-05-01)

Review of TFEB-amplified renal cell carcinoma with focus on clinical and pathobiological aspects
nork: Naoto Kuroda, et al.
Argitaratua: (2022-01-01)

AURKB affects the proliferation of clear cell renal cell carcinoma by regulating fatty acid metabolism
nork: Yang Yang, et al.
Argitaratua: (2025-01-01)

Circulating biomarkers of one-carbon metabolism in relation to renal cell carcinoma incidence and survival.
nork: Johansson, M, et al.
Argitaratua: (2014)

Metabolic syndrome and increased susceptibility to renal cell carcinoma – a meta-analysis
nork: Yanyu Zhou, et al.
Argitaratua: (2025-02-01)

Metabolic subtypes of clear cell renal cell carcinoma defined by tobacco smoking
nork: Maria F. Czyzyk-Krzeska, et al.
Argitaratua: (2021-03-01)

A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma
nork: Renate Pichler, et al.
Argitaratua: (2023-03-01)

Significance of timing of therapeutic line on effectiveness of nivolumab for metastatic renal cell carcinoma
nork: Jun Teishima, et al.
Argitaratua: (2023-03-01)

Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma
nork: Yue Wang, et al.
Argitaratua: (2023-03-01)

Re: In vitro evidence for a new therapeutic approach in renal cell carcinoma
nork: Corrado Spadafora
Argitaratua: (2009-04-01)

The Molecular Basis and Therapeutic Aspects of Cisplatin Resistance in Oral Squamous Cell Carcinoma
nork: Yali Cheng, et al.
Argitaratua: (2021-10-01)

Metabolic and nutritional aspects in continuous renal replacement therapy
nork: Guy Fishman, et al.
Argitaratua: (2023-07-01)

Ultrastructural changes in renal parenchyma with renal cell carcinoma
nork: S. Pasichnyk, et al.
Argitaratua: (2018-06-01)